Related Experiment Video
Updated: Nov 29, 2025

Author Spotlight: Developing a Translational Model for Atrial Fibrillation Research Across Species
Published on: November 21, 2023
The spectrum of lupus myocarditis: from asymptomatic forms to cardiogenic shock
Maya Guglin1, Carson Smith2, Roopa Rao2
1Indiana University School of Medicine, Krannert Institute of Cardiology, 1801 Senate Blvd Suite 2000, Indianapolis, IN, 46202, USA. mguglin@gmail.com.
Insights
Lupus myocarditis, a severe heart condition, is often overlooked when lupus is undiagnosed. Prompt diagnosis and specific treatments, including immunosuppression and advanced cardiac support, can be lifesaving.
Area of Science:
- Cardiology
- Rheumatology
- Immunology
Background:
- Lupus myocarditis is a rare but life-threatening cardiac manifestation of systemic lupus erythematosus.
- It is frequently misdiagnosed, especially when presenting acutely without a prior lupus diagnosis.
- Current management relies heavily on case reports and clinical expertise due to a lack of randomized controlled trials.
Purpose of the Study:
- To review the diagnostic challenges and clinical presentation of lupus myocarditis.
- To highlight cardiogenic shock as a critical manifestation of this condition.
- To discuss current and emerging management strategies for lupus myocarditis.
Main Methods:
- Literature review of lupus myocarditis, focusing on case reports and clinical experience.
- Analysis of diagnostic criteria and clinical presentations.
- Evaluation of treatment modalities, including immunosuppression and mechanical support.
Main Results:
- Lupus myocarditis can present as acute or fulminant myocarditis, often mimicking other causes.
- Cardiogenic shock is a significant and potentially fatal complication.
- Effective management involves aggressive immunosuppression, mechanical circulatory support, and consideration for cardiac transplantation.
Conclusions:
- Lupus myocarditis requires heightened clinical suspicion, particularly in cases of unexplained acute myocarditis.
- Timely and specific treatment, including immunosuppressive therapy and advanced cardiac support, is crucial for improving outcomes.
- Further research, including randomized controlled trials, is needed to optimize treatment protocols.
Abstract:
Lupus myocarditis is a serious, potentially deadly disease. When it presents as an acute or fulminant myocarditis in a patient without an established diagnosis of lupus, lupus as an etiology of the condition is not commonly suspected. Meanwhile, it has a distinct treatment which may be lifesaving. Review of the literature can shed more light as current management is mostly based on clinical experience and case reports rather than randomized control trials. In this review we are discussing this diagnostic entity, focusing on cardiogenic shock as a manifestation of lupus myocarditis, and discussing management including aggressive immunosuppression, mechanical circulatory support, and cardiac transplantation.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis IV: Nursing Management
Rheumatic Heart Disease I: Introduction

